Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Sheppard

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
FEMS Yeast Research|July 13, 2016
α,β-Dicarbonyl reduction is mediated by the Saccharomyces Old Yellow EnzymeBarry van Bergen, Normand Cyr, Rona Strasser, et al.
Investigative Ophthalmology & Visual Science|March 29, 2014
Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized studyJohn D Sheppard, Melissa M Toyos, John H Kempen, et al.
American Journal of Ophthalmology|February 24, 2006
Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin etherJohn D Sheppard, Randy J Epstein, Frank A Lattanzio, et al.
Ophthalmology and Therapy|November 17, 2019
An Evaluation of Staphylococci from Ocular Surface Infections Treated Empirically with Topical Besifloxacin: Antibiotic Resistance, Molecular Characteristics, and Clinical OutcomesBarry A Schechter, John D Sheppard, Christine M Sanfilippo, et al.
Cornea|February 24, 2005
Confocal microscopy used as the definitive, early diagnostic method in Chandler syndromeJohn D Sheppard, Frank A Lattanzio, Patricia B Williams, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 14, 2011
Efficacy of a phosphorodiamidate morpholino oligomer antisense compound in the inhibition of corneal transplant rejection in a rat cornea transplant modelAlireza Hosseini, Frank A Lattanzio, Sandeep S Samudre, et al.
Ophthalmology|April 10, 2019
A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye DiseaseDamien F Goldberg, Ranjan P Malhotra, Barry A Schechter, et al.
Cornea|May 7, 2024
Operating Room Waste Generated From Corneal and Conjunctival SurgeriesShambhawi Thakur, John D Sheppard, Medi Eslani, et al.
Environmental Science & Technology|December 1, 1970
Turbulence promoters for hyperfiltration with dynamic membranesDavid Glen Thomas, Phil H Hayes, William R Mixon, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 3, 2022
Phase 2, Randomized, Open-Label Parallel-Group Study of Two Dosing Regimens of Netarsudil for the Treatment of Corneal Edema Due to Fuchs Corneal DystrophyRichard L Lindstrom, Amber E Lewis, Edward J Holland, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
FEMS Yeast Research|July 13, 2016
α,β-Dicarbonyl reduction is mediated by the Saccharomyces Old Yellow EnzymeBarry van Bergen, Normand Cyr, Rona Strasser, et al.
Investigative Ophthalmology & Visual Science|March 29, 2014
Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized studyJohn D Sheppard, Melissa M Toyos, John H Kempen, et al.
American Journal of Ophthalmology|February 24, 2006
Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin etherJohn D Sheppard, Randy J Epstein, Frank A Lattanzio, et al.
Ophthalmology and Therapy|November 17, 2019
An Evaluation of Staphylococci from Ocular Surface Infections Treated Empirically with Topical Besifloxacin: Antibiotic Resistance, Molecular Characteristics, and Clinical OutcomesBarry A Schechter, John D Sheppard, Christine M Sanfilippo, et al.
Cornea|February 24, 2005
Confocal microscopy used as the definitive, early diagnostic method in Chandler syndromeJohn D Sheppard, Frank A Lattanzio, Patricia B Williams, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 14, 2011
Efficacy of a phosphorodiamidate morpholino oligomer antisense compound in the inhibition of corneal transplant rejection in a rat cornea transplant modelAlireza Hosseini, Frank A Lattanzio, Sandeep S Samudre, et al.
Ophthalmology|April 10, 2019
A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye DiseaseDamien F Goldberg, Ranjan P Malhotra, Barry A Schechter, et al.
Cornea|May 7, 2024
Operating Room Waste Generated From Corneal and Conjunctival SurgeriesShambhawi Thakur, John D Sheppard, Medi Eslani, et al.
Environmental Science & Technology|December 1, 1970
Turbulence promoters for hyperfiltration with dynamic membranesDavid Glen Thomas, Phil H Hayes, William R Mixon, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 3, 2022
Phase 2, Randomized, Open-Label Parallel-Group Study of Two Dosing Regimens of Netarsudil for the Treatment of Corneal Edema Due to Fuchs Corneal DystrophyRichard L Lindstrom, Amber E Lewis, Edward J Holland, et al.
Pageof 6